
Multus Biotechnology is focused on developing and supplying animal-free media that reduces costs for biomanufacturing. They aim to accelerate the commercialization of products like cultivated meat and cell therapies by optimizing media formulations. Their technology involves automating laboratory protocols and using machine learning for formulation optimization, which makes bioprocess scale-up faster and cheaper. They offer custom media manufacturing and licensing of formulations, supporting companies from lab to market with food-safe and reliable media supply. Multus is positioned as a key partner in the cellular agriculture and advanced therapeutics industries, contributing to a more sustainable bioeconomy.

Multus Biotechnology is focused on developing and supplying animal-free media that reduces costs for biomanufacturing. They aim to accelerate the commercialization of products like cultivated meat and cell therapies by optimizing media formulations. Their technology involves automating laboratory protocols and using machine learning for formulation optimization, which makes bioprocess scale-up faster and cheaper. They offer custom media manufacturing and licensing of formulations, supporting companies from lab to market with food-safe and reliable media supply. Multus is positioned as a key partner in the cellular agriculture and advanced therapeutics industries, contributing to a more sustainable bioeconomy.